PM AI Stock Analysis – Buy, Hold, or Avoid?
Philip Morris International Inc. (PM)
Philip Morris International (PM) offers a compelling long-term investment case, driven by robust fundamentals, strong growth in reduced-risk products, and resilient profitability. While short-term technicals indicate possible consolidation or topping, the medium- and long-term outlooks remain positive due to sustained earnings momentum, premium valuation justified by innovation, and favorable analyst sentiment. Investors should be mindful of regulatory and liquidity risks, but the risk/reward profile is attractive for income and growth-oriented portfolios.
Fundamentals
Philip Morris International (PM) demonstrates fundamental stability, with robust revenue growth, consistently high margins, and reliable earnings delivery. The company has a strong market position in the global tobacco industry and continues to show operational resilience, supported by expansion into reduced-risk products and effective cost management. Despite regulatory challenges, PM's steady profitability, attractive dividend, and predictable cash flows reinforce its appeal for income-focused investors.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
9.09% YoY
Q1 2026
Net Income
-9.37% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.1B | 10.4B | 10.8B | 10.1B | 9.3B | 9.7B | 9.9B | 9.5B |
| Revenue Growth YoY | +9.09% | +6.76% | +9.42% | +7.10% | +5.78% | +7.28% | +8.42% | +5.59% |
| Net Income | 2.4B | 2.1B | 3.5B | 3.0B | 2.7B | -579.0M | 3.1B | 2.4B |
| Net Income Growth YoY | -9.37% | +469.78% | +12.85% | +26.31% | +25.23% | -126.37% | +50.05% | +53.44% |
| EPS | $1.56 | $1.37 | $2.23 | $1.95 | $1.72 | -$0.37 | $1.98 | $1.54 |
| EPS Growth YoY | -9.30% | +470.27% | +12.63% | +26.62% | +24.64% | -126.24% | +50.00% | +52.48% |
Profitability Metrics
Gross Margin
TTM
Operating Margin
TTM
Net Margin
TTM
Return on Equity
TTM
Return on Assets
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.06% | 65.64% | 67.85% | 67.66% | 67.32% | 64.73% | 66.04% | 64.67% |
| Operating Margin | 38.37% | 32.55% | 39.31% | 37.01% | 38.10% | 33.58% | 36.87% | 36.38% |
| Net Margin | 24.03% | 20.66% | 32.07% | 29.97% | 28.92% | -5.97% | 31.10% | 25.41% |
| Return on Equity (ROE) | -26.27% | -21.42% | -31.87% | -25.40% | -24.68% | 4.93% | -31.79% | -24.69% |
| Return on Assets (ROA) | 5.90% | 5.22% | 8.98% | 7.62% | 7.30% | -1.71% | 8.15% | 6.54% |
Technical Analysis
PM is currently in a strong bullish trend with price above major moving averages and a golden cross confirming upward momentum. However, technical stage analysis indicates a topping phase with signs of distribution and increased volatility, suggesting caution. RSI is neutral, implying neither overbought nor oversold conditions at present.
Watch for pullback
Price in uptrend
Strong trend active
50 above 200 - bullish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Philip Morris International (PM) demonstrates fundamental stability, with robust revenue growth, consistently high margins, and reliable earnings delivery. The company has a strong market position in the global tobacco industry and continues to show operational resilience, supported by expansion into reduced-risk products and effective cost management. Despite regulatory challenges, PM's steady profitability, attractive dividend, and predictable cash flows reinforce its appeal for income-focused investors.
Latest Earnings
Q1 2026 Earnings (Mar 31, 2026)
Earnings Per Share (EPS)
Actual
$1.96
Estimated
$1.86
Surprise
+$0.10
Surprise %
+5.38%
Revenue
Actual
$10.15B
Estimated
$9.95B
Surprise
+$192.87M
Surprise %
+1.94%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $1.96 | $1.70 | $2.24 | $1.91 | $1.69 | $1.55 | $1.91 | $1.59 |
| EPS (Estimated) | $1.86 | $1.70 | $2.09 | $1.86 | $1.61 | $1.49 | $1.82 | $1.57 |
| EPS Surprise | +$0.10 | +$0.00 | +$0.15 | +$0.05 | +$0.08 | +$0.06 | +$0.09 | +$0.02 |
| % Diff | +5.4% | +0.0% | +7.2% | +2.7% | +5.0% | +4.0% | +4.9% | +1.3% |
| Revenue | ||||||||
| Revenue (Actual) | $10.15B | $10.36B | $10.85B | $10.14B | $9.3B | $9.71B | $9.91B | $9.41B |
| Revenue (Estimated) | $9.95B | $10.4B | $10.64B | $10.32B | $9.14B | $9.44B | $9.68B | $9.19B |
| Revenue Surprise | +$192.87M | -$40.75M | +$209.33M | -$177.57M | +$156.22M | +$269.72M | +$234.85M | +$221.17M |
| % Diff | +1.9% | -0.4% | +2.0% | -1.7% | +1.7% | +2.9% | +2.4% | +2.4% |
Valuation
Philip Morris International's valuation reflects a premium relative to the broader tobacco industry but aligns with its growth prospects and strong profitability. Analysts generally rate the stock as a buy, supported by solid earnings momentum and a growing share of smoke-free product revenues. While its valuation multiples are higher, they are justifiable given the company's resilient margins and adjusted earnings growth outlook.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 26.50 | 29.16 | 18.15 | 23.33 | 22.92 | -80.75 | 15.31 | 16.36 |
| Price to Sales | 25.47 | 24.10 | 23.29 | 27.97 | 26.52 | 19.27 | 19.05 | 16.63 |
| Price to Book | -27.85 | -24.99 | -23.14 | -23.70 | -22.63 | -15.92 | -19.47 | -16.16 |
| Enterprise Value to EBITDA | 71.05 | 65.18 | 62.81 | 78.96 | 72.73 | 52.65 | 56.50 | 52.05 |
| Enterprise Value to Revenue | 30.05 | 28.34 | 27.53 | 32.63 | 31.37 | 23.54 | 23.58 | 21.30 |
Sentiment & Analyst Ratings
Philip Morris International (PM) currently exhibits a predominantly positive market sentiment supported by robust analyst buy recommendations and favorable earnings results. Recent news highlights strong Q1 2026 earnings beating estimates, driven by growth in smoke-free products, though regulatory scrutiny and insider selling introduce some caution. Social media sentiment shows mixed investor views centered on product innovation and regulatory risks, while overall analyst price targets imply expected upside.
Analyst Recommendations
Risk Assessment
Philip Morris International (PM) maintains a solid financial foundation amidst its strategic shift to smoke-free products, contributing substantially to its revenue and growth. While liquidity metrics under 1 raise short-term concerns, the company's strong interest coverage and high operating margins support robust debt servicing capability. Regulatory pressures and market competition in the evolving reduced-risk product landscape pose moderate risks but are balanced by positive analyst outlook and growth potential.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q1 2026
Quick Ratio
Latest Quarter: Q1 2026
Debt-to-Equity
Latest Quarter: Q1 2026
Debt-to-Assets
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 0.98 | 0.96 | 0.85 | 0.83 | 0.79 | 0.88 | 0.89 | 0.94 |
| Quick Ratio | 0.98 | 0.51 | 0.46 | 0.45 | 0.43 | 0.47 | 0.49 | 0.52 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | -5.60 | -4.89 | -4.59 | -4.30 | -4.55 | -3.89 | -5.08 | -5.04 |
| Debt-to-Assets | 0.75 | 0.71 | 0.75 | 0.75 | 0.76 | 0.74 | 0.74 | 0.75 |
Liquidity Assessment
Current Ratio: 0.98(Weak)
Quick Ratio: 0.98(Adequate)
The company has relatively weak liquidity and may face challenges meeting short-term obligations.
Solvency Assessment
Debt-to-Equity: -5.60(Low)
Debt-to-Assets: 0.75(High)
The company has conservative debt levels, indicating low financial risk and strong long-term solvency.
Frequently Asked Questions about PM
AI Answers: Common Questions About PM
Get AI-powered answers to the questions investors ask most about Philip Morris International Inc.
PM is a good buy for medium- and long-term investors, trading at $170.99 with a P/E of 24.05 and strong earnings momentum. The stock is fairly valued given its sector-leading margins (gross margin ~68%, net margin ~24%) and robust growth in smoke-free products. Analyst targets of $192-$197 imply 12-15% upside.
There is no compelling reason to sell unless you are a short-term trader concerned about technical topping or need to reduce exposure to regulatory risk. Fundamentals remain strong, and the company continues to beat earnings expectations. Long-term investors should hold or add on pullbacks.
The biggest risks are regulatory (tightening laws, excise taxes), high leverage (over 75% of assets financed by debt, current ratio below 1), and potential litigation or FX swings. While liquidity is below ideal, strong cash flow and interest coverage mitigate immediate concerns.
Analyst consensus targets are $192-$197, with technical resistance at $191.30 (52-week high). Support is at $164-166 (50/200 SMA), and a breakdown below $164 could trigger a move toward $142.11. Upside of 10-15% is supported by both technical and fundamental analysis.
PM is fairly valued: its P/E of 24.05 and high EV/EBITDA reflect premium pricing versus peers, justified by superior growth in reduced-risk products and free cash flow. The market prices in continued innovation and earnings expansion, with valuation multiples supported by recent performance.
PM is fundamentally strong, with 7.3% revenue growth in 2025, gross margins near 68%, and net margins at ~24%. EPS grew over 60% in 2025, and the company consistently delivers on earnings. However, high leverage and sub-1 liquidity ratios warrant monitoring.
Technically, PM is in a bullish structure above key moving averages with a golden cross, but stage analysis shows a topping phase and possible distribution. RSI is neutral (58.7), so no immediate overbought/oversold signal. Wait for a pullback to $164-166 or a momentum re-acceleration before new entries.
Key catalysts include upcoming earnings reports (given recent beats and raised guidance), continued growth in reduced-risk products (IQOS, ZYN), and regulatory developments, especially FDA decisions on nicotine pouches. Watch for volume/momentum shifts and any major news on litigation or taxation.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.